clopidogrel bisulfate
Commercial- Indications
- Cardiovascular disease
Company intelligence / Profile preview
山东新华制药股份有限公司
Zibo, Shandong Province, Chinaxhzy.com ↗
- Ownership
- Public · 000756
- Development stage
- Commercial
01
Overview
The company has multiple commercial products including aspirin, ibuprofen, and methylcobalamin tablets. Recently received approval for pregalin oral solution and memantine hydrochloride oral solution. Their aspirin enteric-coated tablets (100mg) passed generic drug consistency evaluation.
- Therapeutic areas
- OtherCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculeschemical synthesis drugs
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Beyond the preview
Go deeper on 山东新华制药股份有限公司.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 山东新华制药股份有限公司.